1. Chromosomes and Gene Expression

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

  1. Andrew R Conery
  2. Richard C Centore
  3. Adrianne Neiss
  4. Patricia J Keller
  5. Shivangi Joshi
  6. Kerry L Spillane
  7. Peter Sandy
  8. Charlie Hatton
  9. Eneida Pardo
  10. Laura Zawadzke
  11. Archana Bommi-Reddy
  12. Karen E Gascoigne
  13. Barbara M Bryant
  14. Jennifer A Mertz
  15. Robert J Sims III
https://doi.org/10.7554/eLife.19432
Share this article
Cite this article
  1. Andrew R Conery
  2. Richard C Centore
  3. Adrianne Neiss
  4. Patricia J Keller
  5. Shivangi Joshi
  6. Kerry L Spillane
  7. Peter Sandy
  8. Charlie Hatton
  9. Eneida Pardo
  10. Laura Zawadzke
  11. Archana Bommi-Reddy
  12. Karen E Gascoigne
  13. Barbara M Bryant
  14. Jennifer A Mertz
  15. Robert J Sims III
(2016)
Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
eLife 5:e19432.
https://doi.org/10.7554/eLife.19432
  2. Download BibTeX
  3. Download .RIS

Main text

Conery AR, Centore RC, Neiss A, Keller PJ, Joshi S, Spillane KL, Sandy P, Hatton C, Pardo E, Zawadzke L, Bommi-Reddy A, Gascoigne KE, Bryant BM, Mertz JA, Sims RJ. 2016. Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma. eLife 5:e10483. doi: 10.7554/eLife.10483.

Published January 05, 2016

Owing to a production error the published Supplementary files 1 and 2 were incorrect. Supplementary file 1 was published with the legend for Supplementary file 2 and a file from another eLife article was published with the legend for Supplementary file 1.

The correct Supplementary files 1 and 2 are available here.

Supplementary file 1. Includes qPCR primer sequences and UPL probe numbers for RT-qPCR experiments described in the manuscript.

Supplementary file 2. Indicates the source of all cell lines used, as well as results of mycoplasma testing throughout the course of these studies.

The article has now been corrected accordingly.

Article and author information

Author details

  1. Andrew R Conery

  2. Richard C Centore

  4. Patricia J Keller

  5. Shivangi Joshi

  6. Kerry L Spillane

  7. Peter Sandy

  8. Charlie Hatton

  9. Eneida Pardo

  10. Laura Zawadzke

  11. Archana Bommi-Reddy

  12. Karen E Gascoigne

  13. Barbara M Bryant

  14. Jennifer A Mertz

  15. Robert J Sims III

Version history

  1. Received: July 6, 2016
  2. Accepted: July 6, 2016
  3. Version of Record published: July 14, 2016 (version 1)

Copyright

© 2016, Conery et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 494
    views
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Andrew R Conery
  2. Richard C Centore
  3. Adrianne Neiss
  4. Patricia J Keller
  5. Shivangi Joshi
  6. Kerry L Spillane
  7. Peter Sandy
  8. Charlie Hatton
  9. Eneida Pardo
  10. Laura Zawadzke
  11. Archana Bommi-Reddy
  12. Karen E Gascoigne
  13. Barbara M Bryant
  14. Jennifer A Mertz
  15. Robert J Sims III
(2016)
Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
eLife 5:e19432.
https://doi.org/10.7554/eLife.19432

Share this article

https://doi.org/10.7554/eLife.19432

Categories and tags